Personalising Parkinson’s Drug Response
Parkinson’s disease is the second most common neurodegenerative disorder worldwide, and its incidence is rapidly rising In a significant breakthrough, researchers from
AI Transforms Cancer Care
The study involved 30 research groups across six countries — including Australia, the United States, Canada, Spain, Greece, and Austria — and